首页> CNS spectrums> Comparing two transitioning strategies to paliperidone palmitate once-every-6-months.

Comparing two transitioning strategies to paliperidone palmitate once-every-6-months.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christoph U,Correll

第一单位： Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA.;Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.;Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.;German Center for Mental Health (DZPG), Partner Site, Berlin, Germany.

作者： Christoph U,Correll ^[1] ; Karen L,Johnston ^[2] ; Ibrahim,Turkoz ^[3] ; Michael,Kutch ^[4] ; R Karl,Knight ^[3] ; Monica,Doring ^[2] ; Martha,Sajatovic ^[5]

作者单位： Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA.;Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.;Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.;German Center for Mental Health (DZPG), Partner Site, Berlin, Germany. ^[1] Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Titusville, NJ, USA. ^[2] Janssen Research & Development, LLC, Titusville, NJ, USA. ^[3] Cytel, Cambridge, MA, USA. ^[4] Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.;Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA. ^[5]

关键词 Paliperidone palmitate adult psychiatry clinical trials long-acting injectable antipsychotic mental health relapse-free schizophrenia and psychotic disorders